Document is current
Any future updates will be listed below
-
Authors
Li, Gang
Fife, Daniel
Wang, Grace
Sheehan, John J.
Bodén, Robert
Brandt, Lena
Brenner, Philip
Reutfors, Johan
DiBernardo, Allitia
-
Funding
Funding for this research was provided by:
Janssen Research and Development
Swedish Research Council (2016-02362)
- License Information
-
More Information
Article History
Received: 22 March 2019
Accepted: 13 September 2019
First Online: 30 September 2019
Ethics approval and consent to participate
: Use of the Optum database was reviewed by the New England Institutional Review Board (IRB) and was determined to be exempted from IRB approval, as this project does not involve human subject research. Confidentiality of patient records was always maintained. The study report contains aggregate data only and does not identify individual patients or physicians.
: Not applicable.
: GL, DF, GW, CB, JS, and AD are employees of Janssen Research & Development, LLC and hold stocks in the parent company. LB, PB, RB, and JR are in research collaboration with Janssen for which grant support has been received by Karolinska Institutet. JR has conducted research in collaboration with Abbvie, AstraZeneca, and Pfizer, for which grant/research support has been received by Karolinska Institutet.
